Skip to content

ORTHOPHAR: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ORTHOPHAR

BE 0879.711.212
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€2,109
2024 · €18,082-€15,973
Equity
€257,259
2024 · €255,150+€2,109
Cash
€199,728
2024 · €232,060-€32,331
Balance sheet total
€258,756
2024 · €271,847-€13,090

Largest movements

2024 to 2025
Assets
  • Cash -€32,331

    down €32,331 (-13.9%), from €232,060 to €199,728

    mainly Stocks and contracts (-€20,000) and Other debts (-€15,200)

  • Stocks and contracts +€20,000

    up €20,000 (+62.1%), from €32,193 to €52,193

Equity and liabilities
  • Other debts -€15,200

    down €15,200 (-100%), from €15,200 to €0

Income statement
  • Gross operating margin -€12,574

    down €12,574 (-76.8%), from €16,380 to €3,807

  • Financial income -€2,938

    down €2,938 (-99.0%), from €2,969 to €31

  • Other operating charges +€558

    up €558 (+330%), from €169 to €727

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €18,082
Gross operating margin -€12,574
Other operating charges -€558
Financial income -€2,938
Taxes +€96
Result 2025 €2,109
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€32,331
Investment €0
Financing €0
Cash 2024 €232,060
Net result for the year +€2,109
Stocks and contracts -€20,000
Receivables within one year +€759
Smaller working-capital items +€8
Trade debts -€700
Tax, wage and social debts +€693
Other debts -€15,200
Cash 2025 €199,728
brings cash intakes cash out
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €271,847 €258,756 -€13,090 -4.8%
Current assets 29/58 €271,847 €258,756 -€13,090 -4.8%
Stocks and contracts in progress 3 €32,193 €52,193 +€20,000 +62.1%
Stocks 30/36 €32,193 €52,193 +€20,000 +62.1%
Amounts receivable within one year 40/41 €7,474 €6,714 -€759 -10.2%
Trade receivables 40 €7,474 €145 -€7,328 -98.1%
Other amounts receivable 41 €0 €6,569 +€6,569
Cash at bank and in hand 54/58 €232,060 €199,728 -€32,331 -13.9%
Deferred charges and accrued income 490/1 €120 €120 +€0 +0.3%
Total equity and liabilities 10/49 €271,847 €258,756 -€13,090 -4.8%
Equity 10/15 €255,150 €257,259 +€2,109 +0.8%
Contributions 10/11 €12,200 €12,200 = 0.0%
Reserves 13 €242,950 €245,059 +€2,109 +0.9%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Distributable reserves 133 €241,090 €243,199 +€2,109 +0.9%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €16,696 €1,497 -€15,199 -91.0%
Amounts payable within one year 42/48 €16,647 €1,439 -€15,207 -91.4%
Trade debts 44 €1,323 €623 -€700 -52.9%
Suppliers 440/4 €1,323 €623 -€700 -52.9%
Taxes, remuneration and social security 45 €123 €816 +€693 +562%
Taxes 450/3 €123 €816 +€693 +562%
Other amounts payable 47/48 €15,200 €0 -€15,200 -100%
Accrued charges and deferred income 492/3 €50 €58 +€8 +16.7%
Other operating charges 640/8 €169 €727 +€558 +330%
Gross operating margin 9900 €16,380 €3,807 -€12,574 -76.8%
Operating profit (loss) 9901 €16,211 €3,080 -€13,132 -81.0%
Financial income 75/76B €2,969 €31 -€2,938 -99.0%
Recurring financial income 75 €2,969 €31 -€2,938 -99.0%
Financial charges 65/66B €186 €186 = 0.0%
Recurring financial charges 65 €186 €186 = 0.0%
Profit (loss) for the period before taxes 9903 €18,994 €2,925 -€16,070 -84.6%
Income taxes 67/77 €913 €816 -€96 -10.5%
Profit (loss) for the period 9904 €18,082 €2,109 -€15,973 -88.3%
Profit (loss) for the period to be appropriated 9905 €18,082 €2,109 -€15,973 -88.3%

Source: filed annual accounts (NBB), financial years ended 29 June 2024 and 29 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.